A detailed history of Voya Financial Advisors, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Voya Financial Advisors, Inc. holds 4,502 shares of EW stock, worth $294,790. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,502
Previous 4,453 1.1%
Holding current value
$294,790
Previous $425,000 2.35%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $4,130 - $4,621
49 Added 1.1%
4,502 $415,000
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $137,680 - $181,372
-1,898 Reduced 29.89%
4,453 $425,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $49,861 - $62,830
808 Added 14.58%
6,351 $484,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $19,259 - $25,959
-278 Reduced 4.78%
5,543 $384,000
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $8,873 - $10,281
-109 Reduced 1.84%
5,821 $549,000
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $24,431 - $27,803
-329 Reduced 5.26%
5,930 $490,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $19,602 - $25,095
-287 Reduced 4.38%
6,259 $466,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $20,345 - $26,500
247 Added 3.92%
6,546 $549,000
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $35,897 - $53,232
-415 Reduced 6.18%
6,299 $605,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $82,281 - $103,570
-807 Reduced 10.73%
6,714 $786,000
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $53,929 - $66,254
-507 Reduced 6.32%
7,521 $983,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $3,704 - $4,419
36 Added 0.45%
8,028 $911,000
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $2.85 Million - $3.56 Million
-33,958 Reduced 80.95%
7,992 $828,000
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $137,296 - $158,219
1,745 Added 4.34%
41,950 $3.48 Million
Q4 2020

Mar 05, 2021

BUY
$71.69 - $91.23 $303,965 - $386,815
4,240 Added 11.79%
40,205 $3.6 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $276,352 - $359,640
4,113 Added 12.91%
35,965 $2.82 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $1.26 Million - $1.68 Million
21,841 Added 218.17%
31,852 $2.16 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $60,219 - $93,069
1,149 Added 12.97%
10,011 $1.96 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $10,038 - $11,492
140 Added 1.61%
8,862 $2.06 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $20,249 - $24,816
329 Added 3.92%
8,722 $1.9 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $29,820 - $34,459
535 Added 6.81%
8,393 $1.56 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $20,401 - $27,285
426 Added 5.73%
7,858 $1.48 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $32,626 - $40,028
703 Added 10.45%
7,432 $1.12 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $34,686 - $44,044
759 Added 12.71%
6,729 $1.16 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $9,593 - $11,593
226 Added 3.93%
5,970 $876,000
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $2,305 - $2,941
-62 Reduced 1.07%
5,744 $786,000
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $574 - $669
17 Added 0.29%
5,806 $665,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $210,082 - $224,786
5,789
5,789 $630,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.